These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2076744)

  • 1. Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers.
    Remmert HP; Olling M; Slob W; van der Giesen WF; van Dijk A; Rauws AG
    Eur J Clin Pharmacol; 1990; 39(5):501-5. PubMed ID: 2076744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of activated charcoal on acetaminophen absorption.
    Levy G; Houston JB
    Pediatrics; 1976 Sep; 58(3):432-5. PubMed ID: 958771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration.
    Laine K; Kivistö KT; Pelttari S; Neuvonen PJ
    Pharmacol Toxicol; 1996 Nov; 79(5):270-3. PubMed ID: 8936562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil.
    Laine K; Kivistö KT; Neuvonen PJ
    J Toxicol Clin Toxicol; 1997; 35(3):263-8. PubMed ID: 9140320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.
    Yeates PJ; Thomas SH
    Br J Clin Pharmacol; 2000 Jan; 49(1):11-4. PubMed ID: 10606832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose.
    Mayersohn M; Perrier D; Picchioni AL
    Clin Toxicol; 1977 Dec; 11(5):561-7. PubMed ID: 608318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose.
    Wananukul W; Klaikleun S; Sriapha C; Tongpoo A
    J Med Assoc Thai; 2010 Oct; 93(10):1145-9. PubMed ID: 20973316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anticholinergic drugs on the efficacy of activated charcoal.
    Green R; Sitar DS; Tenenbein M
    J Toxicol Clin Toxicol; 2004; 42(3):267-72. PubMed ID: 15362593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal antidotal dose of activated charcoal.
    Chin L; Picchioni AL; Bourn WM; Laird HE
    Toxicol Appl Pharmacol; 1973 Sep; 26(1):103-8. PubMed ID: 4748129
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Br J Clin Pharmacol; 1999 Aug; 48(2):148-53. PubMed ID: 10417490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of purgatives on antidotal efficacy of oral activated charcoal.
    Neuvonen PJ; Olkkola KT
    Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
    Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
    Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin.
    Mathur LK; Jaffe JM; Colaizzi JL; Moriarty RW
    Am J Hosp Pharm; 1976 Jul; 33(7):717-9. PubMed ID: 941924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry.
    Gomez HF; McClafferty HH; Flory D; Brent J; Dart RC
    Ann Emerg Med; 1997 Nov; 30(5):587-92. PubMed ID: 9360566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion.
    Laine K; Kivistö KT; Ojala-Karlsson P; Neuvonen PJ
    Ther Drug Monit; 1997 Feb; 19(1):46-50. PubMed ID: 9029746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.